SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001654954-23-008900
Filing Date
2023-07-06
Accepted
2023-07-06 17:25:16
Documents
15

Document Format Files

Seq Description Document Type Size
1 DEFA 14A ndra_defa14a.htm   iXBRL DEFA14A 27840
2 PRESS RELEASE ndra_ex991.htm EX-99.1 13196
  Complete submission text file 0001654954-23-008900.txt   165792

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ndra-20230706.xsd EX-101.SCH 5735
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ndra-20230706_lab.xml EX-101.LAB 13542
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ndra-20230706_cal.xml EX-101.CAL 908
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ndra-20230706_pre.xml EX-101.PRE 8537
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ndra-20230706_def.xml EX-101.DEF 2109
9 EXTRACTED XBRL INSTANCE DOCUMENT ndra_defa14a_htm.xml XML 3392
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37969 | Film No.: 231074525
SIC: 3845 Electromedical & Electrotherapeutic Apparatus